World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00001972
Date of registration: 18/01/2000
Prospective Registration: No
Primary sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Public title: PET Scan of Brain Metabolism in Relation to Age and Disease
Scientific title: Positron Emission Tomography Imaging of Human Brain Phospholipid Metabolism in Relation to Age and Disease
Date of first enrolment: September 1994
Target sample size: 123
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00001972
Study type:  Observational
Study design:  N/A  
Phase:  N/A
Countries of recruitment
United States
Contacts
Key inclusion & exclusion criteria

NORMAL VOLUNTEERS:

Age between 18 and 90 years.

No past or current medical condition that would interfere with brain function.

No history of alcoholism, psychiatric or neurological illness, head trauma with loss of
consciousness, history of exposure to central nervous system toxin; history of central
nervous system infection, metabolic, endocrine, connective tissue disease; hypertension or
other cardiovascular disorder; abnormal renal, liver or pulmonary function; blood or
coagulation disease; malignancy; psychopharmacological treatment; neurodegenerative or
neurodevelopmental disorder; stroke; epilepsy; subjects requiring regular medication, and
subjects demonstrated by drug screening to have taken a controlled substance.

No occupational exposure to metal slivers or shavings.

No females who are pregnant or breast feeding.

PATIENTS WITH ALZHEIMER DISEASE:

Age between 18 and 90 years.

Diagnosis of possible or probably Alzheimer Disease according to NINCDS-ADRDA criteria.

Aside from Alzheimer Disease, no past or current medical condition that would interfere
with brain function.

No history of alcoholism, psychiatric or neurological illness, head trauma with loss of
consciousness, history of exposure to central nervous system toxin; history of central
nervous system infection, metabolic, endocrine, connective tissue diseases; hypertension
or other cardiovascular disorder; abnormal renal, liver or pulmonary function; blood or
coagulation disease; malignancy; psychopharmacological treatment.

No females who are pregnant or breast feeding.



Age minimum: N/A
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Brain Neoplasm
Alzheimer's Disease
Niemann Pick Disease
Intervention(s)
Drug: 15 O Water
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
94-N-0205
940205
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history